However, no studies have characterized the effect of AQP inhibitors, either pan-AQP or AQP7-specific inhibitors, as a component of a combination treatment to demonstrate a causal relationship between AQPs and treatment, or if combination treatment can overcome breast cancer metastasis or therapeutic resistance. Here, AQP7 is linked to breast carcinoma.